In a remarkable advancement in orthopaedic medicine, Dr. Douglas J. Fauser, a renowned sports medicine and total joint replacement specialist from Somers Orthopaedic Surgery & Sports Medicine Group, along with Dr. Michael Baroody, a Board-Certified Plastic Surgeon, have achieved a groundbreaking milestone by performing the first autologous live stem cell knee injection at the Orthopaedic & Spine Surgery Center. This revolutionary procedure, conducted on April 22, 2024, under general anesthesia, involved the administration of purified concentrated live stem cells derived from the patient's own abdominal fat, marking a significant step forward in the treatment of osteoarthritis.
Dr. Fauser, who has dedicated more than three decades to delivering high-quality and cost-effective surgical solutions, is at the forefront of non-operative treatments for osteoarthritis. The use of autologous stem cells represents a major advancement in medical treatments, providing patients with an aggressive yet non-surgical option to manage the debilitating effects of osteoarthritis in knees. This pioneering procedure at OSSC utilizes the patient's own body's reparative cells to potentially revolutionize the management of joint degeneration, targeting the underlying causes of osteoarthritis and offering patients a promising new pathway to recovery without surgery.
The procedure highlights the advantages of using adipose tissue in orthopaedics, including its minimal invasiveness, abundance, and superior quality compared to other similar tissues. Fat tissue, known for its cushioning and supportive roles, contains a high concentration of reparative cells that may enhance the healing process. The innovative use of microfragmented adipose tissue, processed by the LIPOGEMS device, exemplifies the potential of fat to play a critical role in orthopaedic and arthroscopic surgeries.
Research, supported by over 160 peer-reviewed publications, confirms the efficacy and safety of using microfragmented fat in various body areas, including shoulders, knees, hips, and feet. This groundbreaking treatment by Drs. Fauser and Baroody at OSSC not only paves the way for future advancements in orthopaedic medicine but also reinforces the center's commitment to providing innovative care that adheres to the highest standards of excellence.
The Orthopaedic & Spine Surgery Center, a leading multi-specialty surgical facility located at Somers Orthopaedic Surgery & Sports Medicine Group's Danbury location, is dedicated to providing outstanding surgical and patient care for a wide range of musculoskeletal conditions. With this first-of-its-kind procedure, OSSC is at the forefront of revolutionizing the treatment of osteoarthritis, offering patients a promising alternative to traditional surgical interventions.
Dr. Fauser emphasized the significance of this milestone, stating, "We are on the brink of a major shift in how we treat osteoarthritis. This first-of-its-kind procedure at OSSC utilizes autologous live stem cells, derived from the patient's own body, to potentially revolutionize the management of joint degeneration. Our goal is not just to alleviate symptoms but to target the underlying causes of osteoarthritis, offering patients a promising new pathway to recovery without surgery."
Somers Orthopaedic Surgery & Sports Medicine Group, founded in 1988, has been at the forefront of diagnosing and treating musculoskeletal conditions. Staffed by board-certified physicians specializing in various orthopaedic disciplines, the group is committed to delivering innovative and effective treatments to their patients. The successful completion of the first autologous live stem cell knee injection at OSSC marks a significant step forward in their mission to provide cutting-edge care for osteoarthritis patients.
